In the present study, we examined the PPARγ expression in tumor cells of patients with MLS by IHC and confirmed PPARγ mRNA expression levels using quantitative RT-PCR (Fig. 2). This evidence concerns the gene PPARG and McLeod neuroacanthocytosis syndrome.